DistantNews
Support us
Johnson & Johnson faces $5.5bn in cancer case payouts amid ongoing lawsuits
๐Ÿ‡ฎ๐Ÿ‡ช Ireland /Health & Science

Johnson & Johnson faces $5.5bn in cancer case payouts amid ongoing lawsuits

From RTร‰ News · () English

Translated from English, summarized and contextualized by DistantNews.

At a glance

News Sources not specified Ongoing story
  • Johnson & Johnson faces over 70,000 lawsuits alleging its talc-based products caused cancer.
  • Plaintiffs claim talc contaminated with asbestos led to ovarian cancer and mesothelioma.
  • The company denies the allegations, calling them

Johnson & Johnson is grappling with more than 70,000 lawsuits claiming its iconic baby powder and other talc-based products caused cancer. The allegations, which date back to 2009, center on claims that the talc caused ovarian cancer or mesothelioma, a rare cancer typically linked to asbestos exposure. Plaintiffs allege that Johnson & Johnson's talc products were contaminated with asbestos, a mineral often found near talc deposits.

The company has consistently denied these claims, labeling them "without merit" and based on "junk science." While Johnson & Johnson reformulated its baby powder and eventually stopped using talc altogether, replacing it with corn starch, it maintained that talc was safe and the reformulation was a response to declining sales driven by online misinformation. Despite winning the "overwhelming majority" of ovarian cancer cases that have gone to trial, the company has faced significant payouts in cases it has lost or settled.

without merit

โ€” Johnson & JohnsonJohnson & Johnson's response to the allegations.

A notable case in 2018 resulted in a $4.7 billion payout to 22 women, later reduced to $2.1 billion on appeal. Crucially, this case forced Johnson & Johnson to release internal documents. These documents revealed the company had detected asbestos traces in its talc as early as 1971 and had concealed this information from authorities and the public for decades. The ongoing litigation, including multidistrict litigation and class action suits, continues to cast a shadow over the company's legacy.

junk science

โ€” Johnson & JohnsonJohnson & Johnson's response to the allegations.
DistantNews Editorial

Originally published by RTร‰ News in English. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.